Research programme: antibacterials - LupinAlternative Names: Antibacterials research programme - Lupin; LL-3522; LL-4858
Latest Information Update: 16 Jul 2016
At a glance
- Originator Lupin
- Class Pyrroles
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in India
- 12 Nov 2004 Data presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2004) have been added to the Bacterial infections antimicrobial activity and pharmacodynamics sections ,
- 02 Sep 2004 Preclinical trials in Bacterial infections in India (unspecified route)